Key Facts

Invested since 2022
Based in Bavaria

About the company

IRUBIS GmbH is a Munich-based startup founded by Anja Müller, Alexander Geißler and Lorenz Sykora-Mirle in 2017. IRUBIS has developed Monipa to bring biological drugs faster to the market. This process analytical technology improves process development and manufacturing of biopharmaceuticals. Monipa is a mid-infrared spectrometer system that enables real-time monitoring and control of important parameters in bioprocessing. It’s single-use interface and the simplifying calibration model, revolutionizes the bioprocess industry. Monipa is already in use by key opinion leaders in the biopharma industry.

Do you want to

know more about this company?

Zum Artikel

Dr. Laura Pedroza Senior Investment Manager

Dr. Laura PedrozaSenior Investment Manager

IRUBIS in the news

Zum Artikel

News

29. August 2024

Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners

Zum Artikel

News

6. October 2022

Real-Time Monitoring of Bioprocesses: IRUBIS closes EUR 2.8m seed round led by HTGF, Verve Ventures and Ventura BioMed Investors